[{"data":1,"prerenderedAt":142},["ShallowReactive",2],{"navigation":3,"research-navigation":16,"index":25,"research-latest":139},[4,8,12],{"title":5,"path":6,"stem":7},"Thesis","\u002Fthesis","1.thesis",{"title":9,"path":10,"stem":11},"Research","\u002Fresearch","2.research",{"title":13,"path":14,"stem":15},"About","\u002Fabout","3.about",[17],{"title":9,"path":10,"stem":18,"children":19,"page":24},"research",[20],{"title":21,"path":22,"stem":23},"AI is speeding up drug discovery. What happens next?","\u002Fresearch\u002Fai-drug-discovery-bottlenecks","research\u002Fai-drug-discovery-bottlenecks",false,{"id":26,"title":27,"body":28,"cta":111,"description":118,"extension":119,"image":120,"links":123,"meta":130,"navigation":131,"path":132,"seo":133,"sitemap":136,"stem":137,"__hash__":138},"index\u002Findex.md","Backing startups building software for biotech and life-science operations.",{"type":29,"value":30,"toc":103},"minimark",[31,36,40,69,73,81,85,88,90,100],[32,33,35],"h2",{"id":34},"what-we-back","What we back",[37,38,39],"p",{},"AI is changing how biotech products are designed. We back the software for the steps that follow: from model to molecule, and from molecule to margins.",[41,42,43,51,57,63],"ul",{},[44,45,46,50],"li",{},[47,48,49],"strong",{},"Lab data and infrastructure."," Platforms that capture experiments and instrument output in a form both scientists and models can use.",[44,52,53,56],{},[47,54,55],{},"Lab automation and orchestration."," Software that plans, runs and tracks experiments across instruments, robotic workcells and cloud labs.",[44,58,59,62],{},[47,60,61],{},"AI for design and development."," Tools for protein and ligand design, formulation and process development.",[44,64,65,68],{},[47,66,67],{},"Manufacturing and quality."," Software for manufacturing execution, batch records and quality, where a validated design becomes a product.",[32,70,72],{"id":71},"how-we-invest","How we invest",[37,74,75,76,80],{},"We invest at pre-seed and seed. We judge a product the way the lab or plant that buys it will: by the work it changes, how it fits their systems and what it takes to pass validation. Founders work directly with the person who makes the investment decision. ",[77,78,79],"a",{"href":14},"Learn more about the firm",".",[32,82,84],{"id":83},"two-markets","Two markets",[37,86,87],{},"The US is our home market, and we also back Nordic founders in Denmark, Sweden, Norway and Finland. The bridge runs both ways: we help Nordic companies land US customers and investors, and US companies reach buyers in Europe.",[32,89,9],{"id":18},[37,91,92,93,96,97,80],{},"We publish our research in the open: the evidence behind our ",[77,94,95],{"href":6},"thesis"," and the questions we're still working through. ",[77,98,99],{"href":10},"Explore our research",[101,102],"latest-research",{},{"title":104,"searchDepth":105,"depth":105,"links":106},"",2,[107,108,109,110],{"id":34,"depth":105,"text":35},{"id":71,"depth":105,"text":72},{"id":83,"depth":105,"text":84},{"id":18,"depth":105,"text":9},{"title":112,"description":113,"links":114},"Building in this space?","We want to meet founders building software for biotech and life-science operations.",[115],{"label":116,"to":117},"Get in touch","mailto:founders@sweaventures.com","Swea Ventures backs early-stage startups building software for biotech and life-science operations in the US and the Nordics.","md",{"src":121,"alt":122},"\u002Fimages\u002Fhero.jpg","Precision instruments and glass samples on a sunlit laboratory worktable.",[124,126],{"label":125,"to":6},"Read our thesis",{"label":127,"to":14,"variant":128,"trailingIcon":129},"About us","soft","i-lucide-arrow-right",{},true,"\u002F",{"title":134,"description":135},"Swea Ventures | Biotech and life-science software","Swea Ventures backs US and Nordic startups building software for biotech and life-science operations.",{"loc":132},"index","7Lbaa5LDC-6W1v_C5kNrUoXT8jXDoTgLZRXPqLu9tTY",{"path":22,"title":21,"date":140,"kind":141},"2026-10-02","Essay",1791476335992]